You have 9 free searches left this month | for more free features.

GBM

Showing 1 - 25 of 914

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Spatiotemporal Dimensions of Metabolism in Autochthonous Tumors

Recruiting
  • Glioblastoma Multiforme
  • Surgical removal of the GBM tumor
  • d4-NAM infusion
  • Orlando, Florida
    AdventHealth Translational Research Institute
Sep 20, 2023

GBM Trial in Nanjing (Postoperative radiotherapy for SVZ)

Recruiting
  • GBM
  • Postoperative radiotherapy for SVZ
  • Nanjing, Jiangsu, China
    Lining Guo
Oct 14, 2023

Glioblastoma Multiforme, Recurrent Glioblastoma Trial in United States (TheraSphere GBM)

Recruiting
  • Glioblastoma Multiforme
  • Recurrent Glioblastoma
  • TheraSphere GBM
  • San Francisco, California
  • +4 more
Aug 15, 2022

Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

Recruiting
  • Glioma, Malignant
  • +6 more
  • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 13, 2023

Recurrent Glioblastoma, Glioblastoma Multiforme, GBM Trial in Charlottesville (5-ALA and Low-Intensity Focused Ultrasound (SDT))

Not yet recruiting
  • Recurrent Glioblastoma
  • +2 more
  • 5-ALA and Low-Intensity Focused Ultrasound (SDT)
  • Charlottesville, Virginia
    University of Virginia
Sep 10, 2023

Glioblastoma Trial (Tofacitinib 5 MG)

Recruiting
  • Glioblastoma
  • Tofacitinib 10mg
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Jan 3, 2023

Glioblastoma Trial in Bayamon, San Juan (Amyvid, Intravenous Solution)

Not yet recruiting
  • Glioblastoma
  • Amyvid, Intravenous Solution
  • Bayamon, Puerto Rico
  • +1 more
Apr 18, 2023

Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

Available
  • Glioblastoma
  • Glioblastoma Multiforme
  • (no location specified)
Sep 19, 2022

Glioblastoma Trial (PEP-CMV vaccine)

Not yet recruiting
  • Glioblastoma
  • PEP-CMV vaccine
  • (no location specified)
Nov 9, 2023

Recurrent Glioblastoma Trial (Sintilimab plus Bevacizumab and Temozolomide)

Not yet recruiting
  • Recurrent Glioblastoma
  • Sintilimab plus Bevacizumab and Temozolomide
  • (no location specified)
Nov 27, 2022

Glioblastoma Trial in Boston (ITI-1001)

Not yet recruiting
  • Glioblastoma
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Jan 13, 2023

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Gut microBIOME in Glioblastoma Patients Receiving

Not yet recruiting
  • Glioblastoma, IDH-wildtype
    • (no location specified)
    Apr 5, 2022

    Glioblastoma, GBM Trial in Suzhou (XS005 Cell Injection, Temozolomide(TMZ))

    Recruiting
    • Glioblastoma
    • GBM
    • Suzhou, Jiangsu, China
      Dushu Lake Hospital Affiliated to Soochow University
    Nov 23, 2023

    Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (VBI-1901, Carmustine, Lomustine)

    Active, not recruiting
    • Glioblastoma Multiforme
    • VBI-1901
    • +2 more
    • Los Angeles, California
    • +3 more
    Jun 27, 2022

    Glioblastoma Multiforme Trial in Stanford, Baltimore (MBG453)

    Active, not recruiting
    • Glioblastoma Multiforme
    • Stanford, California
    • +1 more
    Nov 22, 2022

    Glioblastoma Trial run by the NCI (drug, biological, other)

    Completed
    • Glioblastoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 23, 2022

    Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

    Recruiting
    • Anaplastic Oligoastrocytoma
    • Glioblastoma
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Oct 27, 2022

    Glioblastoma, Adult Trial in Cleveland (Pembrolizumab at 7 days prior, Pembrolizumab at 14 days post, Pembrolizumab at 35 days

    Recruiting
    • Glioblastoma, Adult
    • Pembrolizumab at 7 days prior
    • +3 more
    • Cleveland, Ohio
      University Hospitals Cleveland Medical Center, Case Comprehensiv
    Jan 17, 2023

    Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

    Not yet recruiting
    • Glioma, Malignant
    • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
    • Hiltonol
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University
    Jan 19, 2023

    Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

    Not yet recruiting
    • Glioblastoma Multiforme
    • +3 more
    • P140K-MGMT
    • +5 more
    • Bethesda, Maryland
    • +1 more
    Jul 4, 2022

    Recurrent GBM Trial (SONALA-001 (ALA) and Exablate device)

    Recruiting
    • Recurrent GBM
    • SONALA-001 (ALA) and Exablate device
    • Phoenix, Arizona
    • +2 more
    Jan 6, 2023

    Primary Glioblastoma Trial (AV-GBM-1, Autologous monocytes)

    Not yet recruiting
    • Primary Glioblastoma
    • AV-GBM-1
    • Autologous monocytes
    • (no location specified)
    Dec 14, 2021

    Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome Trial in

    Recruiting
    • Anti-Glomerular Basement Membrane Disease
    • +3 more
    • Chapel Hill, North Carolina
      UNC Kidney Center/Division of Nephrology & Hypertension
    Dec 23, 2022

    Kidney Failure, Acute Trial in Marseille (Apheresis technics)

    Recruiting
    • Kidney Failure, Acute
    • Apheresis technics
    • Marseille, France
      Assisatance Publique Hôpitaux de Marseille
    Mar 22, 2022